Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents
Shukuya, Takehito, Ko, Ryo, Mori, Keita, Kato, Motoyasu, Yagishita, Shigehiro, Kanemaru, Ryota, Honma, Yuichiro, Shibayama, Rina, Koyama, Ryo, Shimada, Naoko, Takahashi, KazuhisaVolume:
76
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2843-3
Date:
October, 2015
File:
PDF, 423 KB
english, 2015